"Vaginal Smears" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Collection of pooled secretions of the posterior vaginal fornix for cytologic examination.
| Descriptor ID |
D014626
|
| MeSH Number(s) |
E01.370.225.500.384.100.800 E01.370.225.998.054.800 E01.370.378.900 E04.074.800 E05.200.500.384.100.800 E05.200.998.054.800 E05.242.384.100.800
|
| Concept/Terms |
Vaginal Smears- Vaginal Smears
- Smear, Vaginal
- Smears, Vaginal
- Vaginal Smear
- Cervical Smears
- Cervical Smear
- Smear, Cervical
- Smears, Cervical
|
Below are MeSH descriptors whose meaning is more general than "Vaginal Smears".
Below are MeSH descriptors whose meaning is more specific than "Vaginal Smears".
This graph shows the total number of publications written about "Vaginal Smears" by people in this website by year, and whether "Vaginal Smears" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 2 | 0 | 2 |
| 2002 | 1 | 5 | 6 |
| 2003 | 2 | 2 | 4 |
| 2004 | 3 | 3 | 6 |
| 2005 | 3 | 6 | 9 |
| 2006 | 3 | 0 | 3 |
| 2007 | 3 | 3 | 6 |
| 2008 | 9 | 2 | 11 |
| 2009 | 3 | 3 | 6 |
| 2010 | 1 | 3 | 4 |
| 2011 | 0 | 4 | 4 |
| 2012 | 1 | 7 | 8 |
| 2013 | 5 | 3 | 8 |
| 2014 | 3 | 2 | 5 |
| 2015 | 4 | 7 | 11 |
| 2016 | 2 | 4 | 6 |
| 2017 | 0 | 4 | 4 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 6 | 6 |
| 2020 | 1 | 3 | 4 |
| 2021 | 2 | 2 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaginal Smears" by people in Profiles.
-
Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV)?testing. J Am Soc Cytopathol. 2024 May-Jun; 13(3):227-232.
-
Efficacy of Cobas HPV testing for predicting grade 2+ cervical intraepithelial neoplasia in a cancer prevention center and a gynecologic oncology clinic: A single-institution experience. Cancer Cytopathol. 2024 Mar; 132(3):152-160.
-
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System. Am J Prev Med. 2024 03; 66(3):540-547.
-
Accuracy of Smartphone Images of the Cervix After Acetic Acid Application for Diagnosing Cervical Intraepithelial Neoplasia Grade 2 or Greater in Women With Positive Cervical Screening: A Systematic Review and Meta-Analysis. JCO Glob Oncol. 2021 12; 7:1711-1721.
-
Cervical Cancer Screening in Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2021 12; 73(12):1796-1803.
-
Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening. J Am Soc Cytopathol. 2021 Jul-Aug; 10(4):399-405.
-
Predictors of timely diagnostic follow-up after an abnormal Pap test among Hispanic women seeking care in El Paso, Texas. BMC Womens Health. 2021 01 06; 21(1):11.
-
The Utility of Blind Pap Tests in Young Adults with Developmental Delay: A Pilot Study. J Pediatr Adolesc Gynecol. 2021 Jun; 34(3):400-403.
-
Prevalence of abnormal cervical cancer screening outcomes among women in the United States: results from the National Health Interview Survey, 2018. Am J Obstet Gynecol. 2020 12; 223(6):938-941.
-
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020 09; 70(5):321-346.